Subscribe
shutterstock_1285184050_stuart_miles
Stuart Miles / Shutterstock.com
3 December 2019Big PharmaSaman Javed

US considers shortening marketing exclusivity to push forward USMCA

The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
New USMCA agreement scraps ten-year marketing exclusivity provision
12 December 2019   The US, Canada and Mexico have signed a new, finalised trade agreement to replace the old North American Free Trade Agreement.
Big Pharma
Global Drug Facility adds new TB drug to its catalogue
31 October 2019   The Global Drug Facility, which provides tuberculosis treatments to those in need in 150 countries, has listed a new drug to its product catalogue.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
New USMCA agreement scraps ten-year marketing exclusivity provision
12 December 2019   The US, Canada and Mexico have signed a new, finalised trade agreement to replace the old North American Free Trade Agreement.
Big Pharma
Global Drug Facility adds new TB drug to its catalogue
31 October 2019   The Global Drug Facility, which provides tuberculosis treatments to those in need in 150 countries, has listed a new drug to its product catalogue.

More on this story

Big Pharma
New USMCA agreement scraps ten-year marketing exclusivity provision
12 December 2019   The US, Canada and Mexico have signed a new, finalised trade agreement to replace the old North American Free Trade Agreement.
Big Pharma
Global Drug Facility adds new TB drug to its catalogue
31 October 2019   The Global Drug Facility, which provides tuberculosis treatments to those in need in 150 countries, has listed a new drug to its product catalogue.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB